. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: Psychoneuroendocrinology. 2020 Sep 16;122:104870. doi: 10.1016/j.psyneuen.2020.104870

Table 5.

Covariance of outcome variables across conditions

Measure	b	SE	95% CI	p-value
*HRV & Cortisol*
HRV & Cortisol	.11	.08	−.05 – .26	.17
*Inflammation & Cortisol*	−.21	.08	−.37 – −.05	.01
IL-6 & Cortisol
TNF-α & Cortisol	.03	.04	−.04 – .10	.39
IFN-γ & Cortisol	.18	.05	.09 – .27	< .001
*Inflammation & HRV*
IL-6 & HRV	.04	.07	−.09 – .17	.56
TNF-α & HRV	−.07	.03	−.14 – −.01	.03
IFN-γ & HRV	−.07	.04	−.15 – .02	.14

Note. IL-6 = interleukin 6; TNF-α = tumor necrosis factor alpha; IFN-γ = interferon gamma; HRV = heart rate variability defined by RMSSD; df = degrees of freedom; CI = confidence interval.